Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Burgess

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Virology|November 17, 2009
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategyMonika Simmons, Timothy Burgess, Julia Lynch, et al.
Military Medicine|November 29, 2019
The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of DefenseChristian Coles, Eugene V Millar, Timothy Burgess, et al.
Nanotechnology|February 10, 2018
Temperature effects in contacts between a metal and a semiconductor nanowire near the degenerate dopingZhuting Sun, Timothy Burgess, Hoe Tan, et al.
Journal of Travel Medicine|November 1, 2017
Reply to JTM-17-106 Comment on 'Guidelines for the prevention of and treatment of travellers' diarrhoea: a graded expert panel report by Riddle et al.'Mark S Riddle, Bradley A Connor, Timothy Burgess, et al.
The American Journal of Tropical Medicine and Hygiene|September 21, 2016
Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human PrimatesMonika Simmons, Robert Putnak, Peifang Sun, et al.
Nano Letters|October 19, 2013
Polarity-driven nonuniform composition in InGaAs nanowiresYa-Nan Guo, Timothy Burgess, Qiang Gao, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbitsKanakatte Raviprakash, Thomas Luke, John Doukas, et al.
Journal of Virological Methods|February 15, 2011
A dendritic cell-based assay for measuring memory T cells specific to dengue envelope proteins in human peripheral bloodPeifang Sun, Charmagne Beckett, Janine Danko, et al.
Virology|October 29, 2011
Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancementPeifang Sun, Karolis Bauza, Subhamoy Pal, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Virology|November 17, 2009
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategyMonika Simmons, Timothy Burgess, Julia Lynch, et al.
Military Medicine|November 29, 2019
The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of DefenseChristian Coles, Eugene V Millar, Timothy Burgess, et al.
Nanotechnology|February 10, 2018
Temperature effects in contacts between a metal and a semiconductor nanowire near the degenerate dopingZhuting Sun, Timothy Burgess, Hoe Tan, et al.
Journal of Travel Medicine|November 1, 2017
Reply to JTM-17-106 Comment on 'Guidelines for the prevention of and treatment of travellers' diarrhoea: a graded expert panel report by Riddle et al.'Mark S Riddle, Bradley A Connor, Timothy Burgess, et al.
The American Journal of Tropical Medicine and Hygiene|September 21, 2016
Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human PrimatesMonika Simmons, Robert Putnak, Peifang Sun, et al.
Nano Letters|October 19, 2013
Polarity-driven nonuniform composition in InGaAs nanowiresYa-Nan Guo, Timothy Burgess, Qiang Gao, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbitsKanakatte Raviprakash, Thomas Luke, John Doukas, et al.
Journal of Virological Methods|February 15, 2011
A dendritic cell-based assay for measuring memory T cells specific to dengue envelope proteins in human peripheral bloodPeifang Sun, Charmagne Beckett, Janine Danko, et al.
Virology|October 29, 2011
Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancementPeifang Sun, Karolis Bauza, Subhamoy Pal, et al.
Pageof 5